AVE Science & Technology Co

AVE Science & Technology Co Earnings Yield

The Earnings Yield of AVE Science & Technology Co (688067.SS) as of Nov 16, 2026 is 1.50 %. In the previous year, Earnings Yield was 1.18 % — a change of 26.72% (higher).

Earnings Yield

1.50 %

YoY

26.72%

Last updated:

Earnings Yield of AVE Science & Technology Co is 2025 1.50 % . Earnings Yield of AVE Science & Technology Co was 2024 1.18 % . It decreases by 26.72% higher compared to the previous year.

The AVE Science & Technology Co Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2018
1.41 CNY
Jan 1, 2019
2.62 CNY
Jan 1, 2020
1.56 CNY
Jan 1, 2021
1.62 CNY
Jan 1, 2022
0.93 CNY
Jan 1, 2023
1.12 CNY
Jan 1, 2024
1.18 CNY
Jan 1, 2025
1.50 CNY
The AVE Science & Technology Co Earnings Yield history
YEAREarnings YieldYoY
1.50 %+26.72%
1.18 %+6.07%
1.12 %+19.81%
0.93 %-42.53%
1.62 %+3.90%
1.56 %-40.42%
2.62 %+85.17%
1.41 %-0.34%
1.42 %-9.62%
1.57 %+23.37%
1.27 %+43.31%
0.89 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AVE Science & Technology Co Stock analysis

What does AVE Science & Technology Co do? AVE Science & Technology Co., Ltd. generates revenue through the research, development, production, sale, and service of clinical testing and analysis instruments. Its main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables. These products are primarily sold to inspection departments within medical and health institutions in both domestic and overseas markets. The company serves healthcare facilities that require diagnostic equipment for laboratory testing and patient care. The firm's product portfolio targets healthcare institutions seeking advanced diagnostic tools for efficient clinical analysis. By focusing on specialized instruments like urine and stool analyzers, AVE Science & Technology addresses specific needs in medical testing departments. The company's domestic and international distribution channels ensure broad market access for its diagnostic solutions. AVE Science & Technology's revenue streams are derived from the sale of its comprehensive range of clinical testing instruments and related consumables. The company's domestic market presence and overseas sales contribute to its overall business performance. Its products support routine diagnostic procedures across various healthcare settings, driving consistent demand for its equipment and reagents. AVE Science & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AVE Science & Technology Co stock

Earnings Yield of AVE Science & Technology Co is 1.50 % in 2025.

Earnings Yield of AVE Science & Technology Co changed from 1.18 % to 1.50 %, representing a 26.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield AVE Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's AVE Science & Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — AVE Science & Technology Co

All Key Metrics — AVE Science & Technology Co